Mira Pharmaceuticals (MIRA) Change in Accured Expenses (2022 - 2025)

Mira Pharmaceuticals has disclosed Change in Accured Expenses across 4 years of filings, most recently posting $45278.0 for Q4 2025.

• Change in Accured Expenses for Q4 2025 came in at $45278.0, up 48.38% year-over-year; the trailing twelve-month figure through Dec 2025 was -$594146.0 (down 421.53% YoY), and the FY2025 annual result was -$594146.0, down 421.53% from the prior year.
• Change in Accured Expenses came in at $45278.0 for Q4 2025 at Mira Pharmaceuticals, up from -$214533.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $347684.0 in Q3 2022 to a low of -$617176.0 in Q1 2025.
• The 4-year median for Change in Accured Expenses is $71487.5 (2024), against an average of -$19915.7.
• Across the five-year window, Change in Accured Expenses surged 132.76% in 2024 and sank 731.72% in 2025, its largest moves.
• Mira Pharmaceuticals' Change in Accured Expenses stood at $172381.0 in 2022, then plunged by 239.81% to -$241008.0 in 2023, then soared by 112.66% to $30515.0 in 2024, then soared by 48.38% to $45278.0 in 2025.
• The last three Change in Accured Expenses figures came in at $45278.0 (Q4 2025), -$214533.0 (Q3 2025), and $192285.0 (Q2 2025), per Business Quant data.